Travere Therapeutics, Inc.
(TVTX - NASDAQ)
40,85 USD
📋 Profilo Aziendale

Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases.

|